Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000345

Type of data
NGS (Exome)
NGS (RNA-seq [MinION])
NGS (RNA-seq [HiSeq 2500])
Access criteria
Controlled-access (Type I)
Total data volume
268 GB
File formats
  • FASTQ
Research
hum0236
Date published
2020-12-10
Date modified
2020-12-10
DDBJ Search
JGAD000345 (opens in a new tab)
JGA Study
JGAS000245 (opens in a new tab)

Analysis method

WES

Materials and participants
non-small cell lung cancer (ICD10: C349): 7 cases
tumor tissues: 7 samples
non-tumor tissues: 7 samples
  • Health status
    Affected
  • Subject count
    7 (Individual)
Disease
  • non-small cell lung cancer
Sample description
DNAs extracted from clinical specimens (tumor tissues and matched non-tumor tissues)
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon V5
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
75 bp
Data use policy
NBDC data sharing policy (JGAP000001)

RNA-seq

Materials and participants
non-small cell lung cancer (ICD10: C349): 7 cases
tumor tissues: 7 samples
non-tumor tissues: 7 samples
  • Health status
    Affected
  • Subject count
    7 (Individual)
Disease
  • non-small cell lung cancer
Sample description
RNAs extracted from clinical specimens (tumor tissues and matched non-tumor tissues)
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
SQK-LSK308
Fragmentation
N/A
Platform
Oxford Nanopore Technologies MinION
Read type
Single-end
Read length
1614 bp (Full-length cDNA, mean read length across all samples)
Data use policy
NBDC data sharing policy (JGAP000001)

RNA-seq

Materials and participants
non-small cell lung cancer (ICD10: C349): 7 cases
tumor tissues: 7 samples
non-tumor tissues: 7 samples
  • Health status
    Affected
  • Subject count
    7 (Individual)
Disease
  • non-small cell lung cancer
Sample description
RNAs extracted from clinical specimens (tumor tissues and matched non-tumor tissues)
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq Stranded mRNA Library Prep Kit
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
75 bp
Data use policy
NBDC data sharing policy (JGAP000001)